Unknown

Dataset Information

0

Concurrent vaccination of boars with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) reduces seminal shedding of type 1 and type 2 PRRSV.


ABSTRACT: The objective of the present study was to determine the effect of concurrent vaccination of boars with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) on seminal shedding of both genotypes. The boars tolerated well concurrent administration of 2 commercial PRRSV vaccines, and no adverse reactions were observed. No interference in the humoral immune response (measured as the level of anti-PRRSV antibodies) or the cell-mediated immune response (measured as the level of PRRSV-specific interferon-?-secreting cells) was observed after concurrent administration compared with single administration of the same vaccines. Concurrent vaccination significantly reduced the load of type 1 and type 2 PRRSV in blood and semen after singular (type 1 or type 2) and dual (type 1 and type 2) PRRSV challenge, and it did not significantly affect the efficacy of each vaccine. The results demonstrate that concurrent vaccination of boars with type 1 and type 2 PRRSV reduces shedding of both genotypes in semen.

SUBMITTER: Jeong J 

PROVIDER: S-EPMC5370536 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Concurrent vaccination of boars with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) reduces seminal shedding of type 1 and type 2 PRRSV.

Jeong Jiwoon J   Park Changhoon C   Kang Ikjae I   Park Su-Jin SJ   Chae Chanhee C  

Canadian journal of veterinary research = Revue canadienne de recherche veterinaire 20170401 2


The objective of the present study was to determine the effect of concurrent vaccination of boars with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) on seminal shedding of both genotypes. The boars tolerated well concurrent administration of 2 commercial PRRSV vaccines, and no adverse reactions were observed. No interference in the humoral immune response (measured as the level of anti-PRRSV antibodies) or the cell-mediated immune response (measured as the level o  ...[more]

Similar Datasets

| S-EPMC3187033 | biostudies-literature
| S-EPMC3923437 | biostudies-literature
| S-EPMC6784018 | biostudies-literature
| S-EPMC7126594 | biostudies-literature
| S-EPMC3666961 | biostudies-literature
| S-EPMC3358207 | biostudies-literature
| S-EPMC8537578 | biostudies-literature
| S-EPMC3248417 | biostudies-literature
| S-EPMC3147358 | biostudies-literature
| S-EPMC5508380 | biostudies-literature